The use of microdialysis to characterize the endocrine production of human subcutaneous adipose tissue in vivo

Regulatory Peptides

Volumn 155, Issue 1-3, 2009, Pages 156-162

  Dostálová, Ivana ^a   Kaválková, Petra ^a   Haluzíková, Denisa ^a   Housová, Jitka ^a   Matoulek, Martin ^a   Haluzík, Martin ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Adipokines; Diurnal rhythm; Glucose; Microdialysis; Proinflammatory cytokines; Trauma

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; GLUCOSE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NERVE GROWTH FACTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESISTIN; SCATTER FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; FEMALE; HUMAN; HUMAN EXPERIMENT; MICRODIALYSIS; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SUBCUTANEOUS FAT; TEST MEAL; TISSUE DISTRIBUTION;

ADIPOKINES; ADIPONECTIN; FEMALE; GLUCOSE; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; LEPTIN; MICRODIALYSIS; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESISTIN; SUBCUTANEOUS FAT; YOUNG ADULT;

EID: 67349149991     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2009.03.008     Document Type: Article

References (52)

1. Kershaw E.E., and Flier J.S. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89 (2004) 2548-2556
2. Scherer P.E. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 55 (2006) 1537-1545
3. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., and Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 372 (1994) 425-432
4. Mohamed-Ali V., Goodrick S., Rawesh A., Katz D.R., Miles J.M., Yudkin J.S., Klein, and Coppack S.W. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 82 (1997) 4196-4200
5. Fasshauer M., Klein J., Neumann S., Eszlinger M., and Paschke R. Tumor necrosis factor alpha is a negative regulator of resistin gene expression and secretion in 3 T3-L1 adipocytes. Biochem Biophys Res Commun 288 (2001) 1027-1031
6. Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., Patel H.R., Ahima R.S., and Lazar M.A. The hormone resistin links obesity to diabetes. Nature 409 (2001) 307-312
7. Haluzík M., Parízková J., and Haluzík M.M. Adiponectin and its role in the obesity-induced insulin resistance and related complications. Physiol Res 53 (2004) 123-129
8. Housa D., Housová J., Vernerová Z., and Haluzík M. Adipocytokines and cancer. Physiol Res 55 (2006) 233-244
9. Yudkin J.S., Coppack S.W., Bulmer K., Rawesh A., and Mohamed-Ali V. Lack of evidence for secretion of plasminogen activator inhibitor-1 by human subcutaneous adipose tissue in vivo. Tromb Res 96 (1999) 1-9
10. Dahlman I., Kaaman M., Olsson T., Tan G.D., Bickerton A.S., Wåhlén K., Andersson J., Nordström E.A., Blomqvist L., Sjögren A., Forsgren M., Attersand A., and Arner P. A unique role of monocyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects. J Clin Endocrinol Metab 90 (2005) 5834-5840
11. I. Dostalova, M. Kunesova, J. Duskova, H. Papezova, J. Nedvidkova, Adipose tissue resistin levels in patients with anorexia nervosa. Nutrition. 200;22:977-83.
12. Dolezalova R., Lacinova Z., Dolinkova M., Kleiblova P., Haluzikova D., Housa D., Papezova H., and Haluzik M. Changes of endocrine function of adipose tissue in anorexia nervosa: comparison of circulating levels versus subcutaneous mRNA expression. Clin Endocrinol (Oxf) 67 (2007) 674-678
13. Ungerstedt U. Microdialysis-principles and applications for studies in animals and man. J Intern Med 230 (1991) 365-373
14. G.F. Clough, Microdialysis of large molecules. AAPS. J. 200;7:E686-92.
15. Sopasakis V.R., Sandqvist M., Gustafson B., Hammarstedt A., Schmelz M., Yang X., Jansson P.A., and Smith U. High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator. Obes Res 12 (2004) 454-460
16. Dostálová I., Kopský V., Dusková J., Papezová H., Pacák K., and Nedvídková J. Leptin concentrations in the abdominal subcutaneous adipose tissue of patients with anorexia nervosa assessed by in vivo microdialysis. Regul Pept 128 (2005) 63-68
17. Højbjerre L., Rosenzweig M., Dela F., Bruun J.M., and Stallknecht B. Acute exercise increases adipose tissue interstitial adiponectin concentration in healthy overweight and lean subjects. Eur J Endocrinol 157 (2007) 613-623
18. Murdolo G., Hammarstedt A., Sandqvist M., Schmelz M., Herder C., Smith U., and Jansson P.A. Monocyte chemoattractant protein-1 in subcutaneous abdominal adipose tissue: characterization of interstitial concentration and regulation of gene expression by insulin. J Clin Endocrinol Metab 92 (2007) 2688-2695
19. Pachler C., Ikeoka D., Plank J., Weinhandl H., Suppan M., Mader J.K., Bodenletz M., Regittnig W., Mangge H., Pieber T.R., and Ellmerer M. Subcutaneous adipose tissue exerts proinflammatory cytokines after minimal trauma in humans. Am J Physiol Endocrinol Metab 293 (2007) E690-E696
20. Murdolo G., Herder C., Wang Z., Rose B., Schmelz M., and Jansson P.A. In situ profiling of adipokines in subcutaneous microdialysates from lean and obese individuals. Am J Physiol Endocrinol Metab 295 (2008) E1095-E1105
21. Zvonic S., Ptitsyn A.A., Conrad S.A., Scott L.K., Floyd Z.E., Kilroy G., Wu X., Goh B.C., Mynatt R.L., and Gimble J.M. Characterization of peripheral circadian clocks in adipose tissues. Diabetes 55 (2006) 962-970
22. Stumvoll M., and Jacob S. Multiple sites of insulin resistance: muscle, liver and adipose tissue. Exp Clin Endocrinol Diabetes 107 (1999) 107-110
23. Wurm S., Neumeier M., Weigert J., Schäffler A., and Buechler C. Plasma levels of leptin, omentin, collagenous repeat-containing sequence of 26-kDa protein (CORS-26) and adiponectin before and after oral glucose uptake in slim adults. Cardiovasc Diabetol 6 (2007) 7
24. Ao X., and Stenken J.A. Microdialysis sampling of cytokines. Methods 38 (2006) 331-341
25. Jacobson I., Sandberg M., and Hamberger A. Mass transfer in brain dialysis devices-a new method for the estimation of extracellular amino acids concentration. J Neurosci Methods 15 (1985) 263-268
26. Zhou Q., and Gallo J.M. In vivo microdialysis for PK and PD studies of anticancer drugs. AAPS J 7 (2005) E659-E667
27. Rosdahl H., Hamrin K., Ungerstedt U., and Henriksson J. A microdialysis method for the in situ investigation of the action of large peptide molecules in human skeletal muscle: detection of local metabolic effects of insulin. Int J Biol Macromol 28 (2000) 69-73
28. Tracey K.J. The inflammatory reflex. Nature 420 (2002) 853-859
29. Anderson J.M., Rodriguez A., and Chang D.T. Foreign body reaction to biomaterials. Semin Immunol 20 (2008) 86-100
30. Orban Z., Remaley A.T., Sampson M., Trajanoski Z., and Chrousos G.P. The differential effect of food intake and beta-adrenergic stimulation on adipose-derived hormones and cytokines in man. J Clin Endocrinol Metab 84 (1999) 2126-2133
31. Petrovsky N., and Harrison L.C. The chronobiology of human cytokine production. Int Rev Immunol 16 (1998) 635-649
32. Gavrila A., Peng C.K., Chan J.L., Mietus J.E., Goldberger A.L., and Mantzoros C.S. Diurnal and ultradian dynamics of serum adiponectin in healthy men: comparison with leptin, circulating soluble leptin receptor, and cortisol patterns. J Clin Endocrinol Metab 88 (2003) 2838-2843
33. Schoenhard J.A., Muldowney III J.A., Emens J.S., Lewy A.J., and Vaughan D.E. Plasminogen activator inhibitor-1 has a circadian rhythm in blind individuals. Thromb Haemost 98 (2007) 479-481
34. Kanabrocki E.L., Hermida R.C., Wright M., Young R.M., Bremner F.W., Third J.L., Ryan M.D., Ayala D.E., Johnson M., Nemchausky B.A., Shirazi P., Scheving L.E., and Olwin J.H. Circadian variation of serum leptin in healthy and diabetic men. Chronobiol Int 18 (2001) 273-283
35. Ahrén B. Diurnal variation in circulating leptin is dependent on gender, food intake and circulating insulin in mice. Acta Physiol Scand 169 (2000) 325-331
36. Bergendahl M., Iranmanesh A., Evans W.S., and Veldhuis J.D. Short-term fasting selectively suppresses leptin pulse mass and 24-hour rhythmic leptin release in healthy midluteal phase women without disturbing leptin pulse frequency or its entropy control (pattern orderliness). J Clin Endocrinol Metab 85 (2000) 207-213
37. Fogteloo A.J., Pijl H., Roelfsema F., Frölich M., and Meinders A.E. Impact of meal timing and frequency on the twenty-four-hour leptin rhythm. Horm Res 62 (2004) 71-78
38. Elimam A., and Marcus C. Meal timing, fasting and glucocorticoids interplay in serum leptin concentrations and diurnal profile. Eur J Endocrinol 147 (2002) 181-188
39. Shea S.A., Hilton M.F., Orlova C., Ayers R.T., and Mantzoros C.S. Independent circadian and sleep/wake regulation of adipokines and glucose in humans. J Clin Endocrinol Metab 90 (2005) 2537-2544
40. van Aggel-Leijssen D.P., van Baak M.A., Tenenbaum R., Campfield L.A., and Saris W.H. Regulation of average 24 h human plasma leptin level; the influence of exercise and physiological changes in energy balance. Int J Obes Relat Metab Disord 23 (1999) 151-158
41. Fenichel R.M., Dominguez J.E., Mayer L., Walsh B.T., Boozer C., and Warren M.P. Leptin levels and luteinizing hormone pulsatility in normal cycling women and their relationship to daily changes in metabolic rate. Fertil Steril 90 (2008) 1161-1168
42. Mullington J.M., Chan J.L., Van Dongen H.P., Szuba M.P., Samaras J., Price N.J., Meier-Ewert H.K., Dinges D.F., and Mantzoros C.S. Sleep loss reduces diurnal rhythm amplitude of leptin in healthy men. J Neuroendocrinol 15 (2003) 851-854
43. Angleton P., Chandler W.L., and Schmer G. Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1). Circulation 79 (1989) 101-106
44. van der Bom J.G., Bots M.L., Haverkate F., and Kluft C. Grobbee DE The 4G5G polymorphism in the gene for PAI-1 and the circadian oscillation of plasma PAI-1. Blood 101 (2003) 1841-1844
45. Yang Y., Tang J.F., Wang Q.D., Li F.Y., Zhang Y.B., Zhou L.B., and Chen M.D. The rhythmicity of adiponectin and its relation with glucocorticoids, insulin and leptin. Zhonghua Nei Ke Za Zhi 43 (2004) 515-518
46. Fain J.N., and Madan A.K. Insulin enhances vascular endothelial growth factor, interleukin-8, and plasminogen activator inhibitor 1 but not interleukin-6 release by human adipocytes. Metabolism 54 (2005) 220-226
47. Gabriely I., Yang X.M., Cases J.A., Ma X.H., Rossetti L., and Barzilai N. Hyperglycemia induces PAI-1 gene expression in adipose tissue by activation of the hexosamine biosynthetic pathway. Atherosclerosis 160 (2002) 115-122
48. He G., Bruun J.M., Lihn A.S., Pedersen S.B., and Richelsen B. Stimulation of PAI-1 and adipokines by glucose in human adipose tissue in vitro. Biochem Biophys Res Commun 310 (2003) 878-883
49. Faraj M., Beauregard G., Tardif A., Loizon E., Godbout A., Cianflone K., Vidal H., and Rabasa-Lhoret R. Regulation of leptin, adiponectin and acylation-stimulating protein by hyperinsulinaemia and hyperglycaemia in vivo in healthy lean young men. Diabetes Metab 34 (2008) 334-342
50. Krusinová E., Klementová M., Kopecký J., Wohl P., Kazdová L., Mlejnek P., Pravenec M., Hill M., and Pelikánová T. Effect of acute hyperinsulinaemia with and without angiotensin II type 1 receptor blockade on resistin and adiponectin concentrations and expressions in healthy subjects. Eur J Endocrinol 157 (2007) 443-449
51. Bougoulia M., Tzotzas T., Efthymiou H., Koliakos G., Konstantinidis T., Triantos A., and Krassas G.E. Leptin concentrations during oral glucose tolerance test (OGTT) in obese and normal weight women. Int J Obes Relat Metab Disord 23 (1999) 625-628
52. Wurm S., Neumeier M., Weigert J., Schäffler A., and Buechler C. Plasma levels of leptin, omentin, collagenous repeat-containing sequence of 26-kDa protein (CORS-26) and adiponectin before and after oral glucose uptake in slim adults. Cardiovasc Diabetol 6 (2007) 7